Genomma Lab Internacional to Report Q3 2026 Earnings
Genomma Lab Internacional announced it will release its third-quarter 2026 financial results on October 21. The company will host a conference call to discuss the results the following day.
Genomma Lab Internacional S.A.B. de C.V. (BMV: LABB), a pharmaceutical and personal care products company, announced it will report its third-quarter 2026 earnings results after the close of the Mexican Stock Exchange (BMV) on Wednesday, October 21, 2026.
The company will hold a conference call on Thursday, October 22, 2026, at 11 a.m. Mexico City Time to discuss its quarterly financial performance. CEO Marco Sparvieri and CFO Antonio Zamora are scheduled to present. A webcast will be available for participants.
Genomma Lab is a significant player in the Mexican pharmaceutical and personal care market, with an expanding international footprint. The company develops, markets, and sells a portfolio of branded products, many of which hold leading market positions. Its business model emphasizes new product development, consumer-focused marketing, broad retail distribution, and operational efficiency.
Previously, Genomma Lab announced its seventeenth dividend payment and a CEO transition. The company's shares are listed on the Mexican Stock Exchange under the ticker LAB B.